Brief: Ascelia Pharma Provides Updated SPARKLE Timelines Due To Covid-19 Impact

Ascelia Pharma AB

20/05/2020 18:43

May 20 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * UPDATED SPARKLE TIMELINES DUE TO COVID-19 IMPACT
    * COVID-19 PANDEMIC IS IMPACTING PACE OF PATIENT
INCLUSION-RATE IN
SPARKLE STUDY
    * ASCELIA PHARMA - COMPLETION AND TOP LINE RESULTS OF
PIVOTAL
PHASE 3 STUDY SPARKLE WITH LEAD COMPOUND MANGORAL NOW EXPECTED
IN H2 2021

Source text for Eikon:  ID:nWkr4yQ0qY 
Further company coverage:  ACELP.ST 

 ((Reuters.Briefs@thomsonreuters.com;))